These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9679927)
1. Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine. Soli M; Bertaccini A; Carparelli F; Gotti R; Cavrini V; Andrisano V; Martorana G J Urol; 1998 Aug; 160(2):551-5. PubMed ID: 9679927 [TBL] [Abstract][Full Text] [Related]
2. Erectile dysfunction: intracavernous treatment. Ledda A Curr Med Res Opin; 2000; 16 Suppl 1():s59-62. PubMed ID: 11329824 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction. Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187 [TBL] [Abstract][Full Text] [Related]
4. The value of a second injection on the pharmaco-induced erection test. Pagani E; Puech-Leão P; Glina S; Reis JM Int J Impot Res; 1997 Sep; 9(3):167-8. PubMed ID: 9315495 [TBL] [Abstract][Full Text] [Related]
5. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction]. Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770 [TBL] [Abstract][Full Text] [Related]
6. A prospective randomized study to optimize the dosage of trimix ingredients and compare its efficacy and safety with prostaglandin E1. Seyam R; Mohamed K; Akhras AA; Rashwan H Int J Impot Res; 2005; 17(4):346-53. PubMed ID: 15772683 [TBL] [Abstract][Full Text] [Related]
7. [Prostaglandin E1 in erectile dysfunction]. Porst H Urologe A; 1989 Mar; 28(2):94-8. PubMed ID: 2655258 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses. Bechara A; Casabé A; Chéliz G; Romano S; Fredotovich N J Urol; 1996 Mar; 155(3):913-4. PubMed ID: 8583605 [TBL] [Abstract][Full Text] [Related]
9. Intracavernous chlorpromazine versus phentolamine: a double-blind clinical comparative study. Shamloul R; El-Dakhly M; Ghanem H; Gadallah A; Mokhtar H J Sex Med; 2004 Nov; 1(3):310-3. PubMed ID: 16422961 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection]. Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the synergistic effects of tamsulosin versus phentolamine on penile erection: in vitro and in vivo studies. Kim SC; Seo KK; Lee SK; Song ES; Lee MY Urol Res; 1999 Dec; 27(6):437-44. PubMed ID: 10651132 [TBL] [Abstract][Full Text] [Related]
12. What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis. Elhanbly S; Schoor R; Elmogy M; Ross L; Hegazy A; Niederberger C J Urol; 2002 Jan; 167(1):192-6. PubMed ID: 11743303 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction. Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479 [TBL] [Abstract][Full Text] [Related]
14. [Percutaneous use of vasoactive drugs in the diagnosis and treatment of erectile impotence]. Pastorini S; Marino G; Cocimano V; Marten Perolino R Minerva Urol Nefrol; 1992; 44(3):191-3. PubMed ID: 1492270 [TBL] [Abstract][Full Text] [Related]
15. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology]. de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917 [TBL] [Abstract][Full Text] [Related]
16. Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study. Shenfeld O; Hanani J; Shalhav A; Vardi Y; Goldwasser B J Urol; 1995 Sep; 154(3):1017-9. PubMed ID: 7637045 [TBL] [Abstract][Full Text] [Related]
17. Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction. Vieillard V; Eychenne N; Astier A; Yiou R; Deffaux C; Paul M Ann Pharm Fr; 2013 Sep; 71(5):358-63. PubMed ID: 24075706 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction. Bechara A; Casabé A; Chéliz G; Romano S; Rey H; Fredotovich N J Urol; 1997 Jun; 157(6):2132-4. PubMed ID: 9146599 [TBL] [Abstract][Full Text] [Related]
19. [Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction]. Porst H Urologe A; 1988 Jan; 27(1):22-6. PubMed ID: 3284144 [TBL] [Abstract][Full Text] [Related]
20. Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction. Kaplan SA; Reis RB; Kohn IJ; Shabsigh R; Te AE Urology; 1998 Nov; 52(5):739-43. PubMed ID: 9801091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]